The role of glial cells in multiple sclerosis disease progression
LM Healy, JA Stratton, T Kuhlmann… - Nature Reviews Neurology, 2022 - nature.com
Despite the development of highly effective treatments for relapsing–remitting multiple
sclerosis (MS), limited progress has been made in addressing primary progressive or …
sclerosis (MS), limited progress has been made in addressing primary progressive or …
The role of glial cells in multiple sclerosis disease progression
LM Healy, JA Stratton, K Tanja… - Nature Reviews …, 2022 - search.proquest.com
Despite the development of highly effective treatments for relapsing–remitting multiple
sclerosis (MS), limited progress has been made in addressing primary progressive or …
sclerosis (MS), limited progress has been made in addressing primary progressive or …
The role of glial cells in multiple sclerosis disease progression.
LM Healy, JA Stratton, T Kuhlmann… - Nature reviews …, 2022 - europepmc.org
Despite the development of highly effective treatments for relapsing-remitting multiple
sclerosis (MS), limited progress has been made in addressing primary progressive or …
sclerosis (MS), limited progress has been made in addressing primary progressive or …
[PDF][PDF] The role of glial cells in multiple sclerosis disease progression
LM Healy, JA Stratton, T Kuhlmann, J Antel - Nature - researchgate.net
Despite the development of highly effective treatments for relapsing–remitting multiple
sclerosis (MS), limited progress has been made in addressing primary progressive or …
sclerosis (MS), limited progress has been made in addressing primary progressive or …
The role of glial cells in multiple sclerosis disease progression
LM Healy, JA Stratton… - Nature reviews …, 2022 - pubmed.ncbi.nlm.nih.gov
Despite the development of highly effective treatments for relapsing-remitting multiple
sclerosis (MS), limited progress has been made in addressing primary progressive or …
sclerosis (MS), limited progress has been made in addressing primary progressive or …